导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.56% | 375/1046 |
| 近一周 | -0.73% | 407/1100 |
| 近一月 | -2.02% | 357/1099 |
| 近一季 | -10.79% | 736/1088 |
| 近半年 | -2.88% | 549/1066 |
| 近一年 | 11.67% | 346/1014 |
| 近两年 | 103.37% | 190/922 |
| 近三年 | 56.12% | 233/830 |
| 成立以来 | 230.11% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.52% 167/1070 |
17.52% 414/1101 |
- - |
- - |
| 2025 | 48.48% 207/1065 |
5.50% 376/1014 |
13.76% 51/1038 |
20.77% 586/1050 |
2.43% 276/1065 |
| 2024 | -3.29% 659/1011 |
-13.06% 855/960 |
-4.08% 577/983 |
13.07% 375/991 |
2.56% 218/1011 |
| 2023 | 13.68% 14/952 |
10.88% 94/880 |
1.60% 110/895 |
-0.80% 107/915 |
1.73% 74/952 |
| 2022 | 12.23% 3/867 |
-2.35% 12/773 |
11.35% 213/806 |
-5.83% 77/845 |
9.60% 86/867 |
| 2021 | 18.41% 160/740 |
0.44% 135/580 |
8.63% 396/659 |
3.08% 164/704 |
5.29% 210/740 |
| 2020 | 18.10% 385/554 |
-6.47% 330/419 |
3.77% 419/466 |
14.27% 156/517 |
6.49% 412/554 |
| 2019 | 17.91% 335/410 |
25.40% 677/1146 |
-6.49% 815/1228 |
-3.99% 369/390 |
4.74% 346/410 |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 国金量化多因子股票A VS. 东吴新产业精选股票A(580008) |